Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 4494 entries
Sorted by: Best Match Show Resources per page
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target.

Pharmacology research & perspectives

Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P.
PMID: 26977298
Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb.

The benefits of novel oral anticoagulants are hampered by bleeding. Since coagulation factor IX (fIX) lies upstream of fX in the coagulation cascade, and intermediate levels have been associated with reduced incidence of thrombotic events, we evaluated the viability...

Cite
Ankrom W, Wood HB, Xu J, et al. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016;4(1):e00207doi: 10.1002/prp2.207.
Ankrom, W., Wood, H. B., Xu, J., Geissler, W., Bateman, T., Chatterjee, M. S., Feng, K. I., Metzger, J. M., Strapps, W. R., Tadin-Strapps, M., Seiffert, D., & Andre, P. (2016). Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacology research & perspectives, 4(1), e00207. https://doi.org/10.1002/prp2.207
Ankrom, Wendy, et al. "Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target." Pharmacology research & perspectives vol. 4,1 (2016): e00207. doi: https://doi.org/10.1002/prp2.207
Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb. PMID: 26977298; PMCID: PMC4777260.
Copy Download .nbib Format: NLM
Epidemiology, diagnosis, and management of atrial fibrillation in women.

International journal of women's health

Poli D, Antonucci E.
PMID: 26089706
Int J Womens Health. 2015 Jun 11;7:605-14. doi: 10.2147/IJWH.S45925. eCollection 2015.

Atrial fibrillation (AF) is the most common arrhythmia and has become a serious public health problem. Moreover, epidemiological data demonstrate that incidence and prevalence of AF are increasing. Several differences in epidemiological patterns, clinical manifestations, and incidence of stroke...

Cite
Poli D, Antonucci E. Epidemiology, diagnosis, and management of atrial fibrillation in women. Int J Womens Health. 2015;7:605-14doi: 10.2147/IJWH.S45925.
Poli, D., & Antonucci, E. (2015). Epidemiology, diagnosis, and management of atrial fibrillation in women. International journal of women's health, 7605-14. https://doi.org/10.2147/IJWH.S45925
Poli, Daniela, and Antonucci, Emilia. "Epidemiology, diagnosis, and management of atrial fibrillation in women." International journal of women's health vol. 7 (2015): 605-14. doi: https://doi.org/10.2147/IJWH.S45925
Poli D, Antonucci E. Epidemiology, diagnosis, and management of atrial fibrillation in women. Int J Womens Health. 2015 Jun 11;7:605-14. doi: 10.2147/IJWH.S45925. eCollection 2015. PMID: 26089706; PMCID: PMC4468997.
Copy Download .nbib Format: NLM
Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke.

Journal of stroke

Jung KH, Yu KH, Kim YD, Park JM, Hong KS, Rha JH, Kwon SU, Bae HJ, Heo JH, Lee BC, Yoon BW.
PMID: 26060808
J Stroke. 2015 May;17(2):210-5. doi: 10.5853/jos.2015.17.2.210. Epub 2015 May 29.

Cardioembolic stroke related to nonvalvular atrial fibrillation is associated with a high recurrence rate and high mortality and morbidity. In this population, therefore, optimal anticoagulant therapy is required to prevent the occurrence of second stroke. Oral anticoagulant, warfarin has...

Cite
Jung KH, Yu KH, Kim YD, et al. Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke. J Stroke. 2015;17(2):210-5doi: 10.5853/jos.2015.17.2.210.
Jung, K. H., Yu, K. H., Kim, Y. D., Park, J. M., Hong, K. S., Rha, J. H., Kwon, S. U., Bae, H. J., Heo, J. H., Lee, B. C., & Yoon, B. W. (2015). Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke. Journal of stroke, 17(2), 210-5. https://doi.org/10.5853/jos.2015.17.2.210
Jung, Keun-Hwa, et al. "Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke." Journal of stroke vol. 17,2 (2015): 210-5. doi: https://doi.org/10.5853/jos.2015.17.2.210
Jung KH, Yu KH, Kim YD, Park JM, Hong KS, Rha JH, Kwon SU, Bae HJ, Heo JH, Lee BC, Yoon BW. Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke. J Stroke. 2015 May;17(2):210-5. doi: 10.5853/jos.2015.17.2.210. Epub 2015 May 29. PMID: 26060808; PMCID: PMC4460340.
Copy Download .nbib Format: NLM
Safety of new oral anticoagulant drugs: a perspective.

Therapeutic advances in drug safety

Vílchez JA, Gallego P, Lip GY.
PMID: 25083259
Ther Adv Drug Saf. 2014 Feb;5(1):8-20. doi: 10.1177/2042098613507945.

The recent development of new oral anticoagulants (NOACs) offers the possibility of efficacy, relative safety and convenience compared with warfarin. This could lead to greater patient compliance, with easier management and improved provision of thromboprophylaxis. Safety whilst using NOACs...

Cite
Vílchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf. 2014;5(1):8-20doi: 10.1177/2042098613507945.
Vílchez, J. A., Gallego, P., & Lip, G. Y. (2014). Safety of new oral anticoagulant drugs: a perspective. Therapeutic advances in drug safety, 5(1), 8-20. https://doi.org/10.1177/2042098613507945
Vílchez, Juan Antonio, et al. "Safety of new oral anticoagulant drugs: a perspective." Therapeutic advances in drug safety vol. 5,1 (2014): 8-20. doi: https://doi.org/10.1177/2042098613507945
Vílchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf. 2014 Feb;5(1):8-20. doi: 10.1177/2042098613507945. PMID: 25083259; PMCID: PMC4110875.
Copy Download .nbib Format: NLM
Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care.

Heart, lung and vessels

Gutsche JT, Riha H, Patel P, Sahota GS, Valentine E, Ghadimi K, Silvay G, Augoustides JG.
PMID: 25024989
Heart Lung Vessel. 2014;6(2):79-87.

There has been significant progress throughout 2013 in cardiothoracic and vascular anaesthesia and intensive care. There has been a revolution in the medical and interventional management of atrial fibrillation. The medical advances include robust clinical risk scoring systems, novel...

Cite
Gutsche JT, Riha H, Patel P, et al. Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care. Heart Lung Vessel. 2014;6(2):79-87
Gutsche, J. T., Riha, H., Patel, P., Sahota, G. S., Valentine, E., Ghadimi, K., Silvay, G., & Augoustides, J. G. (2014). Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care. Heart, lung and vessels, 6(2), 79-87.
Gutsche, J T, et al. "Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care." Heart, lung and vessels vol. 6,2 (2014): 79-87.
Gutsche JT, Riha H, Patel P, Sahota GS, Valentine E, Ghadimi K, Silvay G, Augoustides JG. Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care. Heart Lung Vessel. 2014;6(2):79-87. PMID: 25024989; PMCID: PMC4095834.
Copy Download .nbib Format: NLM
Global assays and the management of oral anticoagulation.

Thrombosis journal

Brinkman HJ.
PMID: 25762867
Thromb J. 2015 Feb 10;13:9. doi: 10.1186/s12959-015-0037-1. eCollection 2015.

Coagulation tests range from global or overall tests to assays specific to individual clotting factors and their inhibitors. Whether a particular test is influenced by an oral anticoagulant depends on the principle of the test and the type of...

Cite
Brinkman HJ. Global assays and the management of oral anticoagulation. Thromb J. 2015;13:9doi: 10.1186/s12959-015-0037-1.
Brinkman, H. J. (2015). Global assays and the management of oral anticoagulation. Thrombosis journal, 139. https://doi.org/10.1186/s12959-015-0037-1
Brinkman, Herm Jan M. "Global assays and the management of oral anticoagulation." Thrombosis journal vol. 13 (2015): 9. doi: https://doi.org/10.1186/s12959-015-0037-1
Brinkman HJ. Global assays and the management of oral anticoagulation. Thromb J. 2015 Feb 10;13:9. doi: 10.1186/s12959-015-0037-1. eCollection 2015. PMID: 25762867; PMCID: PMC4355453.
Copy Download .nbib Format: NLM
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence.

Therapeutic advances in drug safety

Russo V, Rago A, Proietti R, Di Meo F, Antonio Papa A, Calabrò P, D'Onofrio A, Nigro G, AlTurki A.
PMID: 28255434
Ther Adv Drug Saf. 2017 Feb;8(2):67-75. doi: 10.1177/2042098616673990. Epub 2016 Oct 24.

The aim of our article is to provide a concise review for clinicians entailing the main studies that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for thromboembolic stroke prevention in the real-world setting. Atrial fibrillation (AF)...

Cite
Russo V, Rago A, Proietti R, et al. Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Ther Adv Drug Saf. 2016;8(2):67-75doi: 10.1177/2042098616673990.
Russo, V., Rago, A., Proietti, R., Di Meo, F., Antonio Papa, A., Calabrò, P., D'Onofrio, A., Nigro, G., & AlTurki, A. (2017). Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Therapeutic advances in drug safety, 8(2), 67-75. https://doi.org/10.1177/2042098616673990
Russo, Vincenzo, et al. "Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence." Therapeutic advances in drug safety vol. 8,2 (2017): 67-75. doi: https://doi.org/10.1177/2042098616673990
Russo V, Rago A, Proietti R, Di Meo F, Antonio Papa A, Calabrò P, D'Onofrio A, Nigro G, AlTurki A. Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence. Ther Adv Drug Saf. 2017 Feb;8(2):67-75. doi: 10.1177/2042098616673990. Epub 2016 Oct 24. PMID: 28255434; PMCID: PMC5315223.
Copy Download .nbib Format: NLM
Beyond warfarin: The advent of new oral anticoagulants.

The Indian journal of radiology & imaging

Laroia ST, Morales S, Laroia AT.
PMID: 26752818
Indian J Radiol Imaging. 2015 Oct-Dec;25(4):375-9. doi: 10.4103/0971-3026.169459.

New oral anticoagulants (NOAC) are the latest addition to anticoagulant armamentarium. Unlike traditional anti-coagulants like warfarin, lab monitoring and management of bleeding complications secondary to these agents is different. As more and more patients are being switched to these...

Cite
Laroia ST, Morales S, Laroia AT. Beyond warfarin: The advent of new oral anticoagulants. Indian J Radiol Imaging. 2015;25(4):375-9doi: 10.4103/0971-3026.169459.
Laroia, S. T., Morales, S., & Laroia, A. T. (2015). Beyond warfarin: The advent of new oral anticoagulants. The Indian journal of radiology & imaging, 25(4), 375-9. https://doi.org/10.4103/0971-3026.169459
Laroia, Sandeep T, et al. "Beyond warfarin: The advent of new oral anticoagulants." The Indian journal of radiology & imaging vol. 25,4 (2015): 375-9. doi: https://doi.org/10.4103/0971-3026.169459
Laroia ST, Morales S, Laroia AT. Beyond warfarin: The advent of new oral anticoagulants. Indian J Radiol Imaging. 2015 Oct-Dec;25(4):375-9. doi: 10.4103/0971-3026.169459. PMID: 26752818; PMCID: PMC4693386.
Copy Download .nbib Format: NLM
Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums.

World journal of critical care medicine

Gupta S, Tiruvoipati R, Green C, Botha J, Tran H.
PMID: 26261772
World J Crit Care Med. 2015 Aug 04;4(3):202-12. doi: 10.5492/wjccm.v4.i3.202. eCollection 2015 Aug 04.

Thrombocytopenia is often noted in critically ill patients. While there are many reasons for thrombocytopenia, the use of heparin and its derivatives is increasingly noted to be associated with thrombocytopenia. Heparin induced thrombocytopenia syndrome (HITS) is a distinct entity...

Cite
Gupta S, Tiruvoipati R, Green C, et al. Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums. World J Crit Care Med. 2015;4(3):202-12doi: 10.5492/wjccm.v4.i3.202.
Gupta, S., Tiruvoipati, R., Green, C., Botha, J., & Tran, H. (2015). Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums. World journal of critical care medicine, 4(3), 202-12. https://doi.org/10.5492/wjccm.v4.i3.202
Gupta, Sachin, et al. "Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums." World journal of critical care medicine vol. 4,3 (2015): 202-12. doi: https://doi.org/10.5492/wjccm.v4.i3.202
Gupta S, Tiruvoipati R, Green C, Botha J, Tran H. Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums. World J Crit Care Med. 2015 Aug 04;4(3):202-12. doi: 10.5492/wjccm.v4.i3.202. eCollection 2015 Aug 04. PMID: 26261772; PMCID: PMC4524817.
Copy Download .nbib Format: NLM
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events.

Therapeutics and clinical risk management

Mekaj YH, Mekaj AY, Duci SB, Miftari EI.
PMID: 26150723
Ther Clin Risk Manag. 2015 Jun 24;11:967-77. doi: 10.2147/TCRM.S84210. eCollection 2015.

Despite the discovery and application of many parenteral (unfractionated and low-molecular-weight heparins) and oral anticoagulant vitamin K antagonist (VKA) drugs, the prevention and treatment of venous and arterial thrombotic phenomena remain major medical challenges. Furthermore, VKAs are the only...

Cite
Mekaj YH, Mekaj AY, Duci SB, et al. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967-77doi: 10.2147/TCRM.S84210.
Mekaj, Y. H., Mekaj, A. Y., Duci, S. B., & Miftari, E. I. (2015). New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Therapeutics and clinical risk management, 11967-77. https://doi.org/10.2147/TCRM.S84210
Mekaj, Ymer H, et al. "New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events." Therapeutics and clinical risk management vol. 11 (2015): 967-77. doi: https://doi.org/10.2147/TCRM.S84210
Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015 Jun 24;11:967-77. doi: 10.2147/TCRM.S84210. eCollection 2015. PMID: 26150723; PMCID: PMC4485791.
Copy Download .nbib Format: NLM
Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis.

Journal of Korean Neurosurgical Society

Dziedzic TA, Kunert P, Marchel A.
PMID: 28264245
J Korean Neurosurg Soc. 2017 Mar;60(2):232-238. doi: 10.3340/jkns.2015.1212.005. Epub 2017 Mar 01.

OBJECTIVE: An apparent increase of use of drugs affecting hemostasis in our neurosurgical department since the 1990s has encouraged us to investigate whether these drugs influence the clinical course and results of surgery for chronic subdural hematoma (CSDH).METHODS: This...

Cite
Dziedzic TA, Kunert P, Marchel A. Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis. J Korean Neurosurg Soc. 2017;60(2):232-238doi: 10.3340/jkns.2015.1212.005.
Dziedzic, T. A., Kunert, P., & Marchel, A. (2017). Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis. Journal of Korean Neurosurgical Society, 60(2), 232-238. https://doi.org/10.3340/jkns.2015.1212.005
Dziedzic, Tomasz Andrzej, et al. "Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis." Journal of Korean Neurosurgical Society vol. 60,2 (2017): 232-238. doi: https://doi.org/10.3340/jkns.2015.1212.005
Dziedzic TA, Kunert P, Marchel A. Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis. J Korean Neurosurg Soc. 2017 Mar;60(2):232-238. doi: 10.3340/jkns.2015.1212.005. Epub 2017 Mar 01. PMID: 28264245; PMCID: PMC5365289.
Copy Download .nbib Format: NLM
Management of Cavoatrial Deep Venous Thrombosis: Incorporating New Strategies.

Seminars in interventional radiology

Zayed MA, De Silva GS, Ramaswamy RS, Sanchez LA.
PMID: 28265127
Semin Intervent Radiol. 2017 Mar;34(1):25-34. doi: 10.1055/s-0036-1597761.

Cavoatrial deep venous thrombosis (DVT) is diagnosed with increasing prevalence. It can be managed medically with anticoagulation or with directed interventions aimed to efficiently reduce the thrombus burden within the target venous segment. The type of management chosen depends...

Cite
Zayed MA, De Silva GS, Ramaswamy RS, et al. Management of Cavoatrial Deep Venous Thrombosis: Incorporating New Strategies. Semin Intervent Radiol. 2017;34(1):25-34doi: 10.1055/s-0036-1597761.
Zayed, M. A., De Silva, G. S., Ramaswamy, R. S., & Sanchez, L. A. (2017). Management of Cavoatrial Deep Venous Thrombosis: Incorporating New Strategies. Seminars in interventional radiology, 34(1), 25-34. https://doi.org/10.1055/s-0036-1597761
Zayed, Mohamed A, et al. "Management of Cavoatrial Deep Venous Thrombosis: Incorporating New Strategies." Seminars in interventional radiology vol. 34,1 (2017): 25-34. doi: https://doi.org/10.1055/s-0036-1597761
Zayed MA, De Silva GS, Ramaswamy RS, Sanchez LA. Management of Cavoatrial Deep Venous Thrombosis: Incorporating New Strategies. Semin Intervent Radiol. 2017 Mar;34(1):25-34. doi: 10.1055/s-0036-1597761. PMID: 28265127; PMCID: PMC5334491.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 4494 entries